Parameters | Years | Value (%) (range) | References |
---|---|---|---|
Probability | |||
Local Recurrence | 0–5 | 6.5 | [22] |
6–10 | 1.84 | ||
11–15 | 0.325 | ||
NED to metastasis | 0–5 | 18.1 | [23] |
6–10 | 9.2 | ||
11–15 | 5.68 | ||
Metastasis to death | 0–5 | 25.9 | [18] |
6–15 | 15.6 | ||
Normal death | 56–60 (age) | 3.2 | [30] |
61–65 (age) | 4.7 | ||
66–70 (age) | 5.8 | ||
Death due to lung toxicity | 11–15 | 0.49 | [25] |
Death due to heart toxicity | 11–15 | 2.6 | [25] |
Death due to CL breast toxicity | 11–15 | 21.7 | [22] |
SOC PMRT cardiac toxicity | 11–15 | 5.84 | [12] |
SOC PMRT CL breast cancer | 6–15 | 1.0 | [26] |
SOC PMRT lung cancer | 11–15 | 4.4 | [27] |
Utility | |||
 Cardiac toxicity | 11–15 | 0.85 (0.8–0.9) | [35] |
 CL breast cancer | 11–15 | 0.803 (0.708–0.816) | [43] |
 Lung cancer | 11–15 | 0.72 (0.57–0.87) | |
 Recurrence | 0–15 | 0.85 | [18] |
 NED to metastasis | 0–15 | 0.62 | [18] |